Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Public ClinicalTrials.gov record NCT02741323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This study will evaluate the safety and tolerability of MVC in HIV-infected adults receiving a kidney transplant.
Study identification
- NCT ID
- NCT02741323
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2017 (Actual)
- Primary completion
- May 10, 2022 (Actual)
- Completion
- May 10, 2022 (Actual)
- Last update posted
- Aug 21, 2023
2017 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB HIVTR-CCR5 Non-Network CRS | Birmingham | Alabama | 35233-2060 | — |
| UCLA HIVTR-CCR5 Non-Network CRS | Los Angeles | California | 90024 | — |
| UCSF HIVTR-CCR5 Non-network CRS | San Francisco | California | 94118 | — |
| Georgetown HIVTR-CCR5 Non-Network CRS | Washington D.C. | District of Columbia | 20007 | — |
| Emory HIVTR-CCR5 Non-Network CRS | Atlanta | Georgia | 30322 | — |
| Northwestern HIVTR-CCR5 Non-Network CRS | Chicago | Illinois | 60611-2927 | — |
| Univ. of Maryland HIVTR-CCR5 Non-Network CRS | Baltimore | Maryland | 21201 | — |
| JHU HIVTR-CCR5 Non-Network CRS | Baltimore | Maryland | 21287 | — |
| Mt. Sinai Med. Ctr. HIVTR-CCR5 Non-Network CRS | New York | New York | 10029 | — |
| Univ. of Penn HIVTR-CCR5 Non-network CRS | Philadelphia | Pennsylvania | 19104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02741323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02741323 live on ClinicalTrials.gov.